metformin or tirzepatide Do You Still Need If You Take a GLP-1 for Diabetes? Rationale of the Week |

Understanding Inflammation

Overall, the incidence of major adverse CV outcomes was similar between groups (see Table 14)

The more clinically relevant concern involves indirect effects on metabolism and cardiovascular health

It typically takes 30 minutes to start working

In a study published in June in the Journal of Cachexia, Sarcopenia and Muscle , researchers from Tokyo Medical and Dental University (TMDU) reveal that a novel member of a class of medications that is already clinically approved for use in patients with diabetes may also be effective for treating patients with polymyositis (PM)

Action of tyrosinase on alpha and beta-arbutin: A kinetic study